NASDAQ:CDIO
Cardio Diagnostics Holdings, Inc.
Cardio Diagnostics Holdings, Inc.'s revenue fell 57.5% in fiscal 2025 to $14,825 while operating margin fell to −43737.5%. Free cash flow was −$5.9M, −39893.1% of revenue, and the diluted share count rose 95.4%.Summary generated from Cardio Diagnostics Holdings, Inc.'s SEC filings. Latest annual report filed Mar 13, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$14,825
Revenue growth−57.5%
Revenue, 5-yr CAGRn/a
Gross marginn/a
Operating margin−43737.5%
Net margin−43832.5%
ROICn/a
Return on equity−78.6%
Debt / equityn/a
Free cash flow−$5.9M
FCF margin−39893.1%
Share count change+95.4%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating income | −1 | −5 | −7 | −8 | −6 |
| Net income | −1 | −5 | −8 | −8 | −6 |
| Free cash flow | n/a | n/a | −6 | −5 | −6 |
Recent filings
- 4Insider transaction report
Oct 2, 2026 - 4Insider transaction report
Oct 2, 2026 - 8-KResults of a shareholder vote
Sep 18, 2026 - 8-KRegulation FD disclosure
Aug 20, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 7, 2026 - DEF 14AProxy statement
Aug 5, 2026 - 10-QQuarterly report for the period ended Mar 31, 2026
May 15, 2026 - 10-KAnnual report for the fiscal year ended Dec 31, 2025
Mar 13, 2026